A mousse-type sunscreen cosmetic composition and a method for preparing the same
Through specific ingredient combinations and preparation processes, the stability and uniformity issues of mousse-textured sunscreens have been resolved, achieving a lightweight, smooth sunscreen effect suitable for multiple skin types, including oily and dry skin.
Patent Information
- Application Number
- CN202411818647.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-11
- Publication Date
- 2026-02-27
- Estimated Expiration
- 2044-12-11
AI Technical Summary
Existing mousse-textured sunscreens have difficulty maintaining the stability and even distribution of sunscreen ingredients in their formulation design, resulting in uneven application, dragging or sticky feeling, and insufficient adaptability to different skin types.
By using a specific ratio of solvents, sunscreens, moisturizers, emulsifiers, skin conditioners, preservatives, skin protectants, thickeners, and pH adjusters, combined with a precise preparation process, the sunscreen ingredients are ensured to remain stably suspended in the foaming matrix, adapting to the needs of different skin types.
It provides a lightweight, smooth, and evenly applied mousse-textured sunscreen suitable for all skin types, especially oily and dry skin, reducing sun protection blind spots and improving product stability and user comfort.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
TECHNICAL FIELD
[0001] The present application relates to the field of daily chemical technology, in particular to a mousse type sunscreen cosmetic composition and a preparation method thereof. BACKGROUND
[0002] Sunscreen agents with mousse texture are lightweight sunscreen products that present a cream-like texture, giving users a refreshing and non-greasy use experience. The advantage of mousse sunscreen agents lies in their ease of application, rapid absorption, comfort and suitability for oily or mixed skin. Since sunscreen agents need to be maintained on the surface of the skin to form an effective protective layer, in addition to the lightness, the stability of sunscreen ingredients, the protection effect and the adaptability of the skin also need to be considered when designing sunscreen agents with mousse texture.
[0003] Sunscreen agents with mousse texture are suitable for various skin types, especially oily skin and summer use. They do not bring a heavy or greasy feeling to the skin, and can bring a breathable and refreshing feeling. The biggest feature of mousse texture sunscreen agents is that it is very easy to expand when applied, and can be evenly applied to the surface of the skin. Sunscreen ingredients can quickly form a protective layer on the skin without blocking pores or causing discomfort.
[0004] The absorption of organic sunscreen agents varies with different skin types. For example, oily skin may absorb oil-soluble sunscreen agents faster, while dry skin may need to add moisturizing ingredients to improve absorption. High-efficiency sunscreen agents may affect the smoothness of mousse application. If the sunscreen agent is too greasy or has large particles, it may cause a dragging or sticky feeling when applied. Sunscreen agents need to be evenly distributed in the formula, especially physical sunscreen agents, whose particles must be stably suspended in the foaming base to avoid sedimentation or stratification. It is a technical challenge to maintain the effectiveness of sunscreen agents while maintaining the mousse texture, especially in preparation to avoid damaging the sunscreen function of active ingredients.
[0005] In view of the above, the present application provides a mousse type sunscreen cosmetic composition and a preparation method thereof. SUMMARY
[0006] To solve the above technical problems, the present application provides a mousse type sunscreen cosmetic composition, which comprises:
[0007] solvent, sunscreen agent, humectant, filler, emulsifier, emollient, preservative, skin protectant, thickening agent, antioxidant and pH adjuster.
[0008] As an embodiment of the present application, the sunscreen agent is selected from one or more of ethylhexyl methoxy cinnamate, oxybenzone, octocrylene, homosalate, octyl salicylate, avobenzone, benzophenone-3, ensulizole, titanium dioxide, zinc oxide.
[0009] As an embodiment of the present application, the sunscreen agent comprises ethylhexyl methoxy cinnamate, oxybenzone, octocrylene, homosalate, octyl salicylate, avobenzone, benzophenone-3, ensulizole, titanium dioxide, zinc oxide.
[0010] As an embodiment of the present application, the emulsifier comprises cetyl alcohol, glyceryl stearate, PEG-75 stearate, ceteareth-20, steareth-20, sorbitan olivate, potassium cetyl phosphate.
[0011] As an embodiment of the present application, the skin protectant comprises gentiana scabra extract, fomes officinalis extract, avena sativa kernel extract, tetrahydro methyl pyrimidine carboxylic acid.
[0012] As an embodiment of the present application, the bulking agent comprises methyl methacrylate crosspolymer, silica.
[0013] As an embodiment of the present application, the thickening agent comprises sodium polyacrylate, acrylates / C10-30 alkyl acrylate crosspolymer.
[0014] Another aspect of the present application provides a mousse type sunscreen prepared from the mousse type sunscreen cosmetic composition.
[0015] As an embodiment of the present application, the method for preparing the mousse type sunscreen comprises the following steps:
[0016] (1) Pre-disperse the phase A raw materials to a uniform state in advance, and stand by;
[0017] (2) Add the phase B raw materials into a vacuum emulsifying pot, start stirring, and heat to 75-80℃, then add the phase A, vacuumize, homogenize for 5 min, check if the materials are mixed completely, and keep warm for 5-10 min;
[0018] (3) Add the phase C raw materials into an oil pot, stir and heat to 80-85℃, keep warm for 3-5 min, then suck into the emulsifying pot, homogenize for 5-7 min, and start cooling when the material body is uniform without particles;
[0019] (4) When the temperature drops to 45℃, add the phase D raw materials, homogenize and stir for 3 min, vacuumize and defoam, and cool down
[0020] (5) cooling to 35-38℃, and sending for inspection; after the inspection, filtering the product with a 200-mesh screen; sampling and testing, and transferring the product;
[0021] (6) after the inspection, filling and packaging; and after the inspection, storing the finished product.
[0022] Among them, the:
[0023] A phase raw materials: 1 / 3 parts of water, polyacrylic acid sodium, cetyl alcohol phosphate potassium, acrylic acid (ester) / C10-30 alkyl acrylate cross-linked polymer;
[0024] B phase raw materials: remaining water, butanediol, glycerol polyether-26, p-hydroxyacetophenone;
[0025] C phase raw materials: ethylhexyl methoxycinnamate, butylated hydroxytoluene, diethylaminohydroxybenzoyl hexyl benzoate, cetyl alcohol, glycerol stearate, PEG-75 stearate, cetyl alcohol polyether-20, stearyl polyether-20, ethylhexyl palmitate, ethylhexyl triazone, isononyl isononanoate, dimethicone, sorbitan oleate, silica, tocopheryl acetate, bis-ethylhexyloxyphenol methoxyphenyl triazine;
[0026] D phase raw materials: remaining raw materials.
[0027] By adopting the technical scheme, the present application has the following beneficial effects:
[0028] The mousse-textured sunscreen provided by the present application is very light, and does not bring a heavy or sticky feeling to the skin when used, so that the skin feels natural and comfortable. The product has a light covering feeling on the skin and does not block pores, and is suitable for use in hot weather or during exercise. The mousse texture has good spreadability and can quickly and evenly spread on the skin without much rubbing, reducing the dead angles caused by uneven application. The mousse texture is usually smooth and suitable for large-area application, which facilitates quick coverage of the whole body, such as arms, legs and back. DETAILED DESCRIPTION
[0029] The technical scheme of the present application will be described below in a clear and complete manner. Obviously, the described embodiments are only part of the embodiments of the present application, rather than all the embodiments. Based on the embodiments in the present application, all other embodiments obtained by those skilled in the art without creative labor fall within the scope of protection of the present application.
[0030] The present application provides a mousse-type sunscreen cosmetic composition, which contains, by mass:
[0031] Ethylhexyl Methoxy Cinnamate 1-2, Butylated Hydroxytoluene 5-6, Butylene Glycol 1-6, Methyl Methacrylate Crosspolymer 1-4, Glycereth-26 2-6, DEA-Hydroxypenyl Paraben 2-5, Cetyl Alcohol 0.1-0.5, Glyceryl Stearate 0.1-0.5, PEG-75 Stearate 0.1-0.5, Cetyl Alcohol PEG-20 0.1-0.5, Stearyl Alcohol PEG-20 0.1-0.5, Ethylhexyl Palmitate 2-6, Ethylhexyl Triazone 1.5-3, Isocetyl Isononanoate 1.5-4, Dimethicone 1.5-6, 1,2-Hexanediol 0.4-1.2, Sorbitan Oleate 0.2-1, p-Hydroxyacetophenone 0.3-0.6, Silica 0.5-2, Butylene Glycol 0.3-1.5, GENTIANA SCABRA Root Extract 0.7, Sodium Polyacrylate 0.2-0.5, Cetyl Alcohol Phosphate Potassium 0.1-1, Tocopheryl Acetate 0.01-0.5, Acrylates / C10-30 Alkyl Acrylate Crosspolymer 0.2-0.4, Sodium Hydroxide 0.01-0.5, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine 0.05-0.5, Butylene Glycol 0.03, FOMES OFFICINALIS Extract 4.0, Phenoxyethanol 0.01, PEG-40 Hydrogenated Castor Oil 0.05, Butylene Glycol 0.03, AVENASATIVA Kernel Extract 3.5, 1,2-Pentanediol 0.02, Tocopherol (Vitamin E) 0.01-0.5, Tetrahydro methyl Pyrimidine Carboxylic Acid 0.001-1, Water q.s. 100.
[0032] As one embodiment of the present application, the present application provides a mousse-type sunscreen cosmetic composition comprising, by mass:
[0033] Ethylhexyl methoxy cinnamate 1.3, Butylated hydroxytoluene 5.1, Butylene glycol 3.25, Methyl methacrylate crosspolymer 1.54, Glycereth-26 3.14, Diethylamino hydroxybenzoyl hexyl benzoate 3.4, Cetyl alcohol 0.35, Glycerin stearate 0.25, PEG-75 stearate 0.2, Cetyl alcohol PEG-20 0.25, Stearyl alcohol PEG-20 0.25, Ethylhexyl palmitate 3.5, Ethylhexyl triazone 2.1, Isocetyl isononanoate 3.2, Dimethicone 3.2, 1,2-Hexanediol 0.85, Sorbitan olivate 0.32, p-Hydroxyacetophenone 0.4, Silica 1.3, Butylene glycol 0.75, GENTIANA SCABRA root extract 0.7, Sodium polyacrylate 0.3, Cetyl phosphate potassium 0.5, Tocopheryl acetate 0.18, Alkylalkanoates / C10-30 alkyl acrylate crosspolymer 0.3, Sodium hydroxide 1.7, Bis-ethylhexyloxyphenol methoxyphenyl triazine 0.18, Butylene glycol 0.03, FOMES OFFICINALIS extract 4.0, Phenoxyethanol 0.01, PEG-40 hydrogenated castor oil 0.05, Butylene glycol 0.03, AVENA SATIVA kernel extract 3.5, 1,2-Pentanediol 0.02, Tocopherol (vitamin E) 0.1, Tetrahydro methyl pyrimidine carboxylic acid 0.05, Water q.s. to 100 parts.
[0034] As a preferred mode of the present application, the preparation method of the FOMES OFFICINALIS extract is as follows:
[0035] (1) The FOMES OFFICINALIS strain is cultured on solid medium for 5-7 days to obtain an activated strain;
[0036] (2) The activated strain is inoculated into 50 mL of liquid medium and cultured in a shaker (25°C, 150 rpm) for 2-3 days to prepare a seed liquid. The liquid medium comprises 20 g / L of glucose, 5 g / L of yeast extract, 10 g / L of malt extract, 1 g / L of ginsenoside, and 1 L of water.
[0037] (3) The pre-cultured seed liquid is inoculated into 1 L of liquid medium in a fermenter at an inoculation amount of 5-10%, and the fermentation process lasts for 7-14 days. The fermentation temperature is controlled at 25-28°C, the aeration amount is adjusted at 1 vvm, and the stirring speed is set at 150-200 rpm.
[0038] (4) The extract prepared in step (3) is separated to obtain a supernatant; then the supernatant is added with three volumes of ethanol, the precipitate is separated, and the supernatant is taken to obtain the FOMES OFFICINALIS extract.
[0039] As a preferred mode of the present application, the preparation method of the GENTIANA SCABRA root extract is as follows:
[0040] The GENTIANA SCABRA root powder is mixed with 70% ethanol at a ratio of 1:10 (mass / volume ratio) (i.e. 100 grams of powder is added to 1000 mL of 70% ethanol solution).
[0041] The mixture is placed in an ultrasonic instrument for ultrasonic extraction, with the ultrasonic power set to 300 W for 30 minutes, and the temperature controlled at 60°C. After extraction, the extract is cooled to room temperature.
[0042] The solution after extraction is filtered to remove residues, and concentrated under reduced pressure at 45°C until the volume is reduced to 1 / 5 of the original volume; then the extract is freeze-dried to obtain the GENTIANA SCABRA root extract.
[0043] As an embodiment of the present application, the preparation method of the mousse-type sunscreen agent is as follows:
[0044] (1) The A-phase raw materials are pre-soaked and dispersed to a uniform state, ready for use;
[0045] (2) The B-phase raw materials are added to a vacuum emulsifying pot, stirring is started, and heating is performed to 75-80°C, then the A-phase is added, vacuum is applied, homogenization is performed for 5 min, the mixture is checked for completeness, and the temperature is maintained for 5-10 min;
[0046] (3) The C-phase raw materials are added to an oil pot, stirring is started, and the temperature is raised to 80-85°C, maintained for 3-5 min, then added to the emulsifying pot, homogenization is performed for 5-7 min, the mixture is cooled after the material is uniform and there are no particles;
[0047] (4) When the temperature drops to 45°C, the D-phase raw materials are added, homogenization and stirring are performed for 3 min, vacuum is applied to remove foam, and the temperature is lowered
[0048] (5) The temperature is lowered to 35-38°C, and the mixture is checked for quality, then filtered through a 200-mesh sieve. Sampling is performed, and the material is transferred;
[0049] (6) After quality inspection, the mixture is filled and packaged, and the finished product is stored in the warehouse after quality inspection.
[0050] Among them, the:
[0051] The A-phase raw materials are 1 / 3 parts of water, sodium polyacrylate, potassium cetyl phosphate, and acrylate / C10-30 alkyl acrylate crosspolymer;
[0052] The B-phase raw materials are the remaining water, butylene glycol, glycerol polyether-26, and p-hydroxyacetophenone;
[0053] Phase C raw materials: ethylhexyl methoxycinnamate, butylated hydroxytoluene, diethylamino hydroxybenzoyl hexyl benzoate, cetyl alcohol, glyceryl stearate, PEG-75 stearate, cetyl peg-20, steareth-20, ethylhexyl palmitate, ethylhexyl triazone, isononyl isononanoate, dimethicone, sorbitan oleate, silica, tocopheryl acetate, bis-ethylhexyloxyphenol methoxyphenyl triazine;
[0054] Phase D raw materials: remaining raw materials.
[0055] The mousse sunscreen has high requirements for the ratio of emulsifier, water phase and oil phase, and the different types of sunscreen used in the sunscreen product can destroy the balance among the emulsifier, water phase and oil phase. The mousse sunscreen provided by the present application is quickly absorbed, and thus it can be a little dry for dry skin. Therefore, the oat kernel extract is added in the formula to provide a moisturizing film feeling, so that the dry skin can achieve better moisturizing. Meanwhile, the FOMES OFFICINALIS extract is additionally added in the formula to obtain a mousse texture with relatively stable performance. On the one hand, the polysaccharide component contained in the FOMES OFFICINALIS extract can improve the consistency and thus improve the stability. The FOMES OFFICINALIS extract is rich in polysaccharides and polyphenols, and has strong antioxidant capacity and can neutralize free radicals, thereby reducing the damage of ultraviolet rays or environmental pollution to the skin. When the FOMES OFFICINALIS extract is added in the sunscreen mousse, the skin care performance of the product can be improved, and additional skin protection can be provided. However, the FOMES OFFICINALIS extract is sensitive to pH, and thus in the long run, it can affect the stability of the mousse texture. Therefore, the GENTIANA SCABRA root extract and octyl dodecyl phenyl triazole are added to realize the stability and absorption of oily sunscreen.
[0056] Meanwhile, the water phase and the oil phase are stably mixed together according to the preparation process, and are not prone to delamination and separation even under humid and long-term storage conditions.
[0057] The present application is further explained and described below in conjunction with specific embodiments.
[0058] Example 1
[0059] The present embodiment provides a mousse type sunscreen cosmetic composition, which contains the following components by mass:
[0060] Ethylhexyl methoxy cinnamate 1.3, Butylated hydroxytoluene 5.1, Butylene glycol 3.25, Methyl methacrylate crosspolymer 1.54, Glycereth-26 3.14, Diethylamino hydroxybenzoyl hexyl benzoate 3.4, Cera alba 0.35, Glyceryl stearate 0.25, PEG-75 stearate 0.2, Cetyl peg-200 0.25, Stearyl peg-200 0.25, Ethylhexyl palmitate 3.5, Ethylhexyl triazone 2.1, Isocetyl isononanoate 3.2, Dimethicone 3.2, 1,2-Hexanediol 0.85, Sorbitan olivate 0.32, p-Hydroxyacetophenone 0.4, Silica 1.3, Butylene glycol 0.75, GENTIANA SCABRA root extract 0.7, Sodium polyacrylate 0.3, Cetyl alcohol phosphate potassium 0.5, Tocopheryl acetate 0.18, Acrylates / C10-30 alkyl acrylate crosspolymer 0.3, Sodium hydroxide 1.7, Bis-ethylhexyloxyphenol methoxyphenyl triazine 0.18, Butylene glycol 0.03, FOMES OFFICINALIS extract 4.0, Phenoxyethanol 0.01, PEG-40 hydrogenated castor oil 0.05, Butylene glycol 0.03, AVENASATIVA kernel extract 3.5, 1,2-Pentanediol 0.02, Tocopherol (vitamin E) 0.1, Tetrahydro methyl pyrimidine carboxylic acid 0.05, Octyldodecylphenyl triazone 0.05, Water q.s. to 100.
[0061] The FOMES OFFICINALIS extract is prepared by the following method:
[0062] (1) The FOMES OFFICINALIS strain is cultured on solid medium (7% agar MS solid medium) for 5-7 days to obtain an activated strain.
[0063] (2) The activated strain is inoculated into 50 mL of liquid medium and cultured in a shaker (25°C, 150 rpm) for 2-3 days to prepare a seed liquid. The liquid medium comprises 20 g / L of glucose, 5 g / L of yeast extract, 10 g / L of malt extract, 1 g / L of ginsenoside, and 1 L of water.
[0064] (3) The pre-cultured seed liquid is inoculated into 1 L of liquid medium in a fermenter at an inoculation amount of 5-10%, and the fermentation process is continued for 7-14 days. The fermentation temperature is controlled at 25-28°C, the aeration amount is adjusted to 1vvm, and the stirring speed is set to 150-200 rpm.
[0065] (4) The extract prepared in step (3) is separated to obtain a supernatant, and then the supernatant is added to three volumes of ethanol, the precipitate is separated, and the supernatant is taken to obtain the FOMES OFFICINALIS extract.
[0066] wherein the GENTIANA SCABRA root extract is prepared as follows:
[0067] Gentiana scabra root powder is mixed with 70% ethanol in a ratio of 1:10 (mass / volume) (i.e. 100 grams of powder is added to 1000 mL of 70% ethanol solution).
[0068] The mixture is placed in an ultrasonic instrument for ultrasonic extraction, with the ultrasonic power set to 300 W for 30 minutes, and the temperature controlled at 60°C. After extraction, the extract is cooled to room temperature.
[0069] The solution after extraction is filtered to remove residues, and concentrated under reduced pressure at 45°C until the volume is reduced to 1 / 5 of the original volume; then the extract is freeze-dried to obtain the GENTIANA SCABRA root extract.
[0070] wherein the present embodiment provides a mousse-type sunscreen, and the preparation method thereof comprises the following steps:
[0071] (1) The A-phase raw materials are pre-soaked and dispersed to a uniform state, and stand by;
[0072] (2) The B-phase raw materials are added to a vacuum emulsifying pot, stirring is started, and heating is performed to 75-80°C, then the A-phase is added, vacuum is drawn, homogenization is performed for 5 min, the mixture is checked for completeness, and the temperature is maintained for 5-10 min;
[0073] (3) The C-phase raw materials are added to an oil pot, stirring is started, and the temperature is raised to 80-85°C, then the emulsifying pot is drawn in after maintaining the temperature for 3-5 min, homogenization is performed for 5-7 min, and the material is cooled after the material body is uniform and free of particles;
[0074] (4) When the temperature drops to 45°C, the D-phase raw materials are added, homogenization and stirring are performed for 3 min, vacuum is drawn to remove foam, and the temperature is lowered
[0075] (5) The temperature is lowered to 35-38°C, and the material is sent for inspection, and after passing the inspection, the material is filtered out through a 200-mesh sieve. Sampling and detection are performed, and the material body is transferred;
[0076] (6) After passing the inspection, the material is filled and packaged, and after passing the inspection, the finished product is stored in the warehouse.
[0077] wherein the:
[0078] A-phase raw materials: 1 / 3 parts of water, sodium polyacrylate, potassium cetyl phosphate, and acrylate / C10-30 alkyl acrylate crosspolymer;
[0079] B-phase raw materials: the remaining water, butylene glycol, glycereth-26, and p-hydroxyacetophenone;
[0080] C phase raw materials: ethylhexyl methoxy cinnamate, butylated hydroxytoluene, diethylamino hydroxybenzoyl hexyl benzoate, cetyl alcohol, glyceryl stearate, PEG-75 stearate, cetyl alcohol polyether-20, stearyl alcohol polyether-20, ethylhexyl palmitate, ethylhexyl triazone, isononyl isononanoate, dimethicone, sorbitan oleate, silica, tocopheryl acetate, bis-ethylhexyloxyphenol methoxyphenyl triazine, octyldodecylphenyl triazone;
[0081] D phase raw materials: remaining raw materials.
[0082] Example 2
[0083] The present embodiment provides a mousse type sunscreen cosmetic composition comprising, by mass parts:
[0084] Ethylhexyl methoxy cinnamate 1.3, butylated hydroxytoluene 5.1, butylene glycol 3.25, methyl methacrylate crosspolymer 1.54, glyceryl polyether-26 3.14, diethylamino hydroxybenzoyl hexyl benzoate 3.4, cetyl alcohol 0.35, glyceryl stearate 0.25, PEG-75 stearate 0.2, cetyl alcohol polyether-20 0.25, stearyl alcohol polyether-20 0.25, ethylhexyl palmitate 3.5, ethylhexyl triazone 2.1, isononyl isononanoate 3.2, dimethicone 3.2, 1,2-hexanediol 0.85, sorbitan oleate 0.32, p-hydroxyacetophenone 0.4, silica 1.3, butylene glycol 0.75, GENTIANA SCABRA root extract 0.7, sodium polyacrylate 0.3, potassium cetyl phosphate 0.5, tocopheryl acetate 0.18, acrylates / C10-30 alkyl acrylate crosspolymer 0.3, sodium hydroxide 1.7, bis-ethylhexyloxyphenol methoxyphenyl triazine 0.18, butylene glycol 0.03, FOMES OFFICINALIS extract 4.0, phenoxyethanol 0.01, PEG-40 hydrogenated castor oil 0.05, butylene glycol 0.03, 1,2-pentanediol 0.02, tocopherol (vitamin E) 0.1, tetrahydro methyl pyrimidine carboxylic acid 0.05, octyldodecylphenyl triazone 0.05 parts, beta-glucan 3.5 parts, and water is supplemented to 100 parts.
[0085] The preparation method of the FOMES OFFICINALIS extract is as follows:
[0086] (1) The FOMES OFFICINALIS strain is cultured on a solid culture medium (7% agar MS stationary culture medium) for 5-7 days to obtain an activated strain;
[0087] (2) The activated strain is inoculated into 50 mL of liquid medium and cultured in a shaker (25°C, 150 rpm) for 2-3 days to prepare a seed liquid. The liquid medium contains 20 g / L of glucose, 5 g / L of yeast extract, 10 g / L of malt extract, 1 g / L of ginsenoside, and 1 L of water.
[0088] (3) The pre-cultured seed liquid is inoculated into 1 L of liquid medium in a fermenter at an inoculation amount of 5-10%, and the fermentation process lasts for 7-14 days. The fermentation temperature is controlled at 25-28°C, the aeration amount is adjusted to 1 vvm, and the stirring speed is set to 150-200 rpm.
[0089] (4) The extract prepared in step (3) is separated to obtain a supernatant, and then the supernatant is added to three volumes of ethanol, the precipitate is separated, and the supernatant is obtained, thereby obtaining the Fomes officinalis extract.
[0090] The preparation method of the Gentiana scabra root extract is as follows:
[0091] The Gentiana scabra root powder is mixed with 70% ethanol at a ratio of 1:10 (mass / volume ratio) (i.e., 100 g of powder is added to 1000 mL of 70% ethanol solution).
[0092] The mixture is placed in an ultrasonic instrument for ultrasonic extraction, the ultrasonic power is set to 300 W, and the extraction lasts for 30 minutes at a temperature of 60°C. After extraction, the extract is cooled to room temperature.
[0093] The extracted solution is filtered to remove residues, and is concentrated under reduced pressure at 45°C until the volume is reduced to 1 / 5 of the original volume. Then, the extract is freeze-dried to obtain the Gentiana scabra root extract.
[0094] In this embodiment, a mousse-type sunscreen is provided, and the preparation method is the same as that of Example 1, and the order of adding the replaced components is unchanged.
[0095] Example 3
[0096] This embodiment provides a mousse-type sunscreen cosmetic composition, which contains the following components by mass:
[0097] Ethylhexyl methoxy cinnamate 1.3, butylated hydroxytoluene 5.1, butylene glycol 3.25, methyl methacrylate crosspolymer 1.54, glycereth-26 3.14, diethyl hydroxylbenzoyl hexyl benzoate 3.4, cetyl alcohol 0.35, glyceryl stearate 0.25, PEG-75 stearate 0.2, cetyl alcohol polyether-20 0.25
[0098] Stearoxyethyleneglycol 0.25, Ethylhexyl Palmitate 3.5, Ethylhexyl Triazone 2.1, Isocetyl Isononanoate 3.2, Dimethicone 3.2, 1,2-Hexanediol 0.85, Sorbitan Olivate 0.32, Para-Hydroxyacetophenone 0.4, Silica 1.3, Butylene Glycol 0.75, GENTIANA SCABRA Root Extract 0.7, Sodium Polyacrylate 0.3, Potassium Cetyl Phosphate 0.5, Tocopheryl Acetate 0.18, Acrylates / C10-30 Alkyl Acrylate Crosspolymer 0.3, Sodium Hydroxide 1.7, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine 0.18, Butylene Glycol 0.03, Phenoxyethanol 0.01, PEG-40 Hydrogenated Castor Oil 0.05, Butylene Glycol 0.03, AVENA SATIVA Kernel Extract 3.5, 1,2-Pentanediol 0.02, Tocopherol (Vitamin E) 0.1, Tetrahydrodronyphimurium Carboxylic Acid 0.05, Octyldodecylphenyl Triazone 0.05, Beta-Glucan 4.0, Water q.s. to 100.
[0099] The GENTIANA SCABRA root extract is prepared as follows:
[0100] The GENTIANA SCABRA root powder is mixed with 70% ethanol at a ratio of 1:10 (mass / volume) (i.e. 100 grams of powder is added to 1000 mL of 70% ethanol solution).
[0101] The mixture is placed in an ultrasonic instrument for ultrasonic extraction, with the ultrasonic power set to 300 W for 30 minutes, and the temperature controlled at 60°C. After extraction, the extract is cooled to room temperature.
[0102] The residue is removed by filtration from the extracted solution, which is concentrated under reduced pressure at 45°C until the volume is reduced to 1 / 5 of the original volume. The extract is then freeze-dried to obtain the GENTIANA SCABRA root extract.
[0103] The mousse-type sunscreen of the present embodiment is prepared according to the method of Example 1, with the order of addition of the replaced ingredients unchanged.
[0104] Example 4
[0105] The mousse-type sunscreen cosmetic composition of the present embodiment comprises, by mass:
[0106] Ethylhexyl methoxy cinnamate 1.35, Butylated hydroxytoluene 5.1, Butylene glycol 3.25, Methyl methacrylate crosspolymer 1.54, Glycereth-26 3.14, Diethylamino hydroxybenzoyl hexyl benzoate 3.4, Cetyl alcohol 0.35, Glyceryl stearate 0.25, PEG-75 stearate 0.2, Cetyl alcohol PEG-20 0.25, Stearyl alcohol PEG-20 0.25, Ethylhexyl palmitate 3.5, Ethylhexyl triazone 2.1, Isocetyl isononanoate 3.2, Dimethicone 3.2, 1,2-Hexanediol 0.85, Sorbitan olivate 0.32, p-Hydroxyacetophenone 0.4, Silica 1.3, Butylene glycol 0.75, Sodium polyacrylate 0.3, Cetyl alcohol phosphate potassium 0.5, Tocopheryl acetate 0.18, Acrylates / C10-30 alkyl acrylate crosspolymer 0.3, Sodium hydroxide 1.7, Bis-ethylhexyloxyphenol methoxyphenyl triazine 0.18, Butylene glycol 0.03, Fomes officinalis extract 4.0, Phenoxyethanol 0.01, PEG-40 hydrogenated castor oil 0.05, Butylene glycol 0.03, Avena sativa kernel extract 3.5, 1,2-Pentanediol 0.02, Tocopherol (vitamin E) 0.1, Tetrahydro methyl pyrimidine carboxylic acid 0.05, Beta-glucan 0.75 parts, Water q.s. to 100 parts.
[0107] The Fomes officinalis extract is prepared by the following method:
[0108] (1) The Fomes officinalis strain is cultured on a solid medium (7% agar MS stationary medium) for 5-7 days to obtain an activated strain.
[0109] (2) The activated strain is inoculated into 50 mL of liquid medium and cultured in a shaker (25°C, 150 rpm) for 2-3 days to prepare a seed liquid. The liquid medium comprises 20 g / L of glucose, 5 g / L of yeast extract, 10 g / L of malt extract, 1 g / L of ginsenoside, and 1 L of water.
[0110] (3) The pre-cultured seed liquid is inoculated into 1 L of liquid medium in a fermenter at an inoculation amount of 5-10%, and the fermentation process lasts for 7-14 days. The fermentation temperature is controlled at 25-28°C, the aeration amount is adjusted at 1 vvm, and the stirring speed is set at 150-200 rpm.
[0111] (4) The extract prepared in step (3) is separated to obtain a supernatant, and then the supernatant is added with three volumes of ethanol, the precipitate is separated, and the supernatant is taken to obtain the Fomes officinalis extract.
[0112] In the present embodiment, a mousse type sunscreen is provided, which is prepared according to the method of Example 1, and the order of adding the replaced components is unchanged.
[0113] Example 5
[0114] In the present embodiment, a mousse type sunscreen cosmetic composition is provided, which comprises, by mass:
[0115] Ethylhexyl methoxy cinnamate 1.3, Butylated hydroxytoluene 5.1, Butylene glycol 3.25, Methyl methacrylate crosspolymer 1.54, Glycereth-26 3.14, Diethylamino hydroxybenzoyl hexyl benzoate 3.4, Cetyl alcohol 0.35, Glyceryl stearate 0.25, PEG-75 stearate 0.2, Cetyl alcohol PEG-20 0.25, Stearyl alcohol PEG-20 0.25, Ethylhexyl palmitate 3.5, Ethylhexyl triazone 2.1, Isocetyl isononanoate 3.2, Dimethicone 3.2, 1,2-Hexanediol 0.85, Sorbitan olivate 0.32, Para-hydroxyacetophenone 0.4, Silica 1.3, Butylene glycol 0.75, GENTIANA SCABRA root extract 0.7, Sodium polyacrylate 0.3, Cetyl phosphate potassium 0.5, Tocopheryl acetate 0.18, Acrylates / C10-30 alkyl acrylate crosspolymer 0.3, Sodium hydroxide 1.7, Bis-ethylhexyloxyphenol methoxyphenyl triazine 0.18, Butylene glycol 0.03, FOMES OFFICINALIS extract 4.0, Phenoxyethanol 0.01, PEG-40 hydrogenated castor oil 0.05, Butylene glycol 0.03, AVENA SATIVA kernel extract 3.5, 1,2-Pentanediol 0.02, Tocopherol (Vitamin E) 0.1, Tetrahydro methyl pyrimidine carboxylic acid 0.05, Octyldodecylphenyl triazone 0.05, and water is added to 100 parts.
[0116] In the present embodiment, a mousse type sunscreen cosmetic composition is provided, which comprises, by mass:
[0117] (1) The FOMES OFFICINALIS strain is cultured on a solid medium (7% agar MS solid medium) for 5-7 days to obtain an activated strain.
[0118] (2) The activated strain is inoculated into 50 mL of liquid medium and cultured in a shaker (25°C, 150 rpm) for 2-3 days to prepare a strain liquid. The liquid medium comprises: glucose 20 g / L, yeast extract 5 g / L, malt extract 10 g / L, and water 1 L.
[0119] (3) The pre-cultured seed liquid is inoculated into the liquid medium in the 1 L fermenter at an inoculation amount of 5-10%, and the fermentation process lasts for 7-14 days. The fermentation temperature is controlled at 25-28°C; the aeration amount is adjusted at 1 vvm, and the stirring speed is set at 150-200 rpm.
[0120] (4) The extract prepared in step (3) is separated to obtain the supernatant; then the supernatant is added into three volumes of ethanol, the precipitate is separated, and the precipitate is taken to obtain the Fomes officinalis extract.
[0121] The preparation method of the Gentiana scabra root extract is as follows:
[0122] The Gentiana scabra root powder is mixed with 70% ethanol at a ratio of 1:10 (mass / volume ratio) (i.e. 100 grams of powder is added into 1000 mL of 70% ethanol solution).
[0123] The mixture is placed in an ultrasonic instrument for ultrasonic extraction, the ultrasonic power is set at 300 W, and the temperature is controlled at 60°C for 30 minutes. After extraction, the extract is cooled to room temperature.
[0124] The extracted solution is filtered to remove the residue, and concentrated under reduced pressure at 45°C until the volume is reduced to 1 / 5 of the original volume; then the extract is freeze-dried to obtain the Gentiana scabra root extract.
[0125] In this embodiment, a mousse-type sunscreen is provided, and the preparation method is the same as that in Embodiment 1, and the order of adding the replaced components is unchanged.
[0126] Embodiment 6
[0127] This embodiment provides a mousse-type sunscreen cosmetic composition, which contains the following components by mass:
[0128] Ethylhexyl methoxy cinnamate 1.3, Butylated hydroxytoluene 5.1, Butylene glycol 3.25, Methyl methacrylate crosspolymer 1.54, Glycereth-26 3.14, Diethylamino hydroxybenzoyl hexyl benzoate 3.4, Cetyl alcohol 0.35, Glyceryl stearate 0.25, PEG-75 stearate 0.2, Cetyl alcohol PEG-20 0.25, Stearyl alcohol PEG-20 0.25, Ethylhexyl palmitate 3.5, Ethylhexyl triazone 2.1, Isocetyl isononanoate 3.2, Dimethicone 3.2, 1,2-Hexanediol 0.85, Sorbitan olivate 0.32, p-Hydroxyacetophenone 0.4, Silica 1.3, Butylene glycol 0.75, GENTIANA SCABRA root extract 0.7, Sodium polyacrylate 0.3, Cetyl phosphate potassium 0.5, Tocopheryl acetate 0.18, Acrylates / C10-30 alkyl acrylate crosspolymer 0.3, Sodium hydroxide 1.7, Bis-ethylhexyloxyphenol methoxyphenyl triazine 0.18, Butylene glycol 0.03, FOMES OFFICINALIS extract 4.0, Phenoxyethanol 0.01, PEG-40 hydrogenated castor oil 0.05, Butylene glycol 0.03, AVENA SATIVA kernel extract 3.5, 1,2-Pentanediol 0.02, Tocopherol (vitamin E) 0.1, Tetrahydro methyl pyrimidine carboxylic acid 0.05, Octyldodecylphenyl triazone 0.05, Water q.s. to 100.
[0129] wherein the FOMES OFFICINALIS extract is prepared by the following method:
[0130] (1) The FOMES OFFICINALIS strain is cultured on solid medium (7% agar MS solid medium) for 5-7 days to obtain an activated strain;
[0131] (2) The activated strain is inoculated into 50 mL of liquid medium and cultured in a shaker (25°C, 150 rpm) for 2-3 days to prepare a seed liquid. The liquid medium comprises 20 g / L of glucose, 5 g / L of yeast extract, 10 g / L of malt extract, 1 g / L of ginsenoside, and 1 L of water.
[0132] (3) The pre-cultured seed liquid is inoculated into 1 L of liquid medium in a fermenter at an inoculation amount of 5-10%, and the fermentation process lasts for 7-14 days. The fermentation temperature is controlled at 25-28°C, the aeration amount is adjusted at 1 vvm, and the stirring speed is set at 150-200 rpm.
[0133] (4) The extract prepared in step (3) is separated to obtain a supernatant; then the supernatant is added with three volumes of ethanol, the precipitate is separated, and the supernatant is taken to obtain the FOMES OFFICINALIS extract.
[0134] The preparation method of the Gentiana scabra root extract is as follows:
[0135] The Gentiana scabra root powder is mixed with 70% ethanol at a ratio of 1:10 (mass / volume) (i.e., 100 grams of powder is added to 1000 mL of 70% ethanol solution).
[0136] The mixture is placed in an ultrasonic instrument for ultrasonic extraction, with the ultrasonic power set to 300 W and the temperature controlled at 60°C for 30 minutes. After extraction, the extract is cooled to room temperature.
[0137] The extracted solution is filtered to remove residues, and concentrated under reduced pressure at 45°C until the volume is reduced to 1 / 5 of the original volume. Then, the extract is freeze-dried to obtain the Gentiana scabra root extract.
[0138] The preparation method of the mousse-type sunscreen provided in the embodiment is as follows:
[0139] (1) The A-phase raw materials are pre-soaked and dispersed to a uniform state, and standby;
[0140] (2) The B-phase raw materials are added to a vacuum emulsifying pot, stirring is started, and heating is performed to 75-80°C. Then, the A-phase is added, vacuum is drawn, homogenization is performed for 5 minutes, the mixture is checked for completeness, and temperature is maintained for 5-10 minutes;
[0141] (3) The C-phase raw materials are added to an oil pot, stirring is started, and temperature is raised to 80-85°C. After temperature is maintained for 3-5 minutes, the mixture is drawn into the emulsifying pot, homogenization is performed for 5-7 minutes, and the mixture is cooled after the material is uniform and there are no particles;
[0142] (4) When the temperature drops to 45°C, the D-phase raw materials are added, homogenization and stirring are performed for 3 minutes, vacuum is drawn to remove foam, and temperature is lowered
[0143] (5) The temperature is lowered to 35-38°C, and the mixture is sent for inspection. After inspection, the mixture is filtered through a 200-mesh sieve. The sample is taken for detection, and the material is transferred;
[0144] (6) After inspection, the mixture is filled and packaged. After inspection, the finished product is stored in the warehouse.
[0145] The preparation method of the mousse-type sunscreen provided in the embodiment is as follows:
[0146] The A-phase raw materials include 1 / 3 parts of water, sodium polyacrylate, potassium cetyl phosphate, and acrylate / C10-30 alkyl acrylate crosspolymer;
[0147] B phase raw materials: remaining water, butylene glycol, glycereth-26, para-hydroxyacetophenone, oat (AVENA SATIVA) kernel extract, FOMES OFFICINALIS extract;
[0148] C phase raw materials: ethylhexyl methoxy cinnamate, butylated hydroxytoluene, diethylamino hydroxybenzoyl hexyl benzoate, cetyl alcohol, glyceryl stearate, PEG-75 stearate, cetyl alcohol ether-20, stearyl alcohol ether-20, ethylhexyl palmitate, ethylhexyl triazone, isononyl isononanoate, dimethicone, sorbitan oleate, silica, tocopheryl acetate, bis-ethylhexyloxyphenol methoxyphenyl triazine, octyldodecylphenyl triazone;
[0149] D phase raw materials: remaining raw materials.
[0150] Example 7
[0151] The present embodiment provides a mousse type sunscreen cosmetic composition, which comprises, by mass parts:
[0152] Ethylhexyl methoxy cinnamate 1.3, butylated hydroxytoluene 5.1, butylene glycol 3.25, methyl methacrylate crosspolymer 1.54, glycereth-26 3.14, diethylamino hydroxybenzoyl hexyl benzoate 3.4, ethylhexyl palmitate 3.5, ethylhexyl triazone 2.1, isononyl isononanoate 3.2, dimethicone 3.2, 1,2-hexanediol 0.85, sorbitan oleate 1.62, para-hydroxyacetophenone 0.4, silica 1.3, butylene glycol 0.75, GENTIANA SCABRA root extract 0.7, sodium polyacrylate 0.3, cetyl alcohol phosphate potassium 0.5, tocopheryl acetate 0.18, acrylates / C10-30 alkyl acrylate crosspolymer 0.3, sodium hydroxide 1.7, bis-ethylhexyloxyphenol methoxyphenyl triazine 0.18, butylene glycol 0.03, FOMES OFFICINALIS extract 4.0, phenoxyethanol 0.01, PEG-40 hydrogenated castor oil 0.05, butylene glycol 0.03, AVENA SATIVA kernel extract 3.5, 1,2-pentanediol 0.02, tocopherol (vitamin E) 0.1, tetrahydro methyl pyrimidine carboxylic acid 0.05, octyldodecylphenyl triazone 0.05, and water is supplemented to 100 parts.
[0153] The preparation method of the FOMES OFFICINALIS extract is as follows:
[0154] (1) The FOMES OFFICINALIS strain is cultured on a solid culture medium (7% agar MS stationary culture medium) for 5-7 days to obtain an activated strain;
[0155] (2) Activate the strain and inoculate into 50 mL of liquid medium, and incubate in a shaker (25°C, 150 rpm) for 2-3 days to prepare a seed liquid. The liquid medium contains 20 g / L of glucose, 5 g / L of yeast extract, 10 g / L of malt extract, 1 g / L of ginsenoside, and 1 L of water.
[0156] (3) The pre-cultured seed liquid is inoculated into 1 L of liquid medium in a fermenter at an inoculation amount of 5-10%, and the fermentation process lasts for 7-14 days. The fermentation temperature is controlled at 25-28°C, the aeration amount is adjusted to 1 vvm, and the stirring speed is set to 150-200 rpm.
[0157] (4) The extract prepared in step (3) is separated to obtain a supernatant; then the supernatant is added to three volumes of ethanol, the precipitate is separated, and the supernatant is obtained, thereby obtaining the Fomes officinalis extract.
[0158] The preparation method of the Gentiana scabra root extract is as follows:
[0159] The Gentiana scabra root powder is mixed with 70% ethanol at a ratio of 1:10 (mass / volume ratio) (i.e., 100 g of powder is added to 1000 mL of 70% ethanol solution).
[0160] The mixture is placed in an ultrasonic instrument for ultrasonic extraction, the ultrasonic power is set to 300 W, and the extraction lasts for 30 minutes at a temperature of 60°C. After extraction, the extract is cooled to room temperature.
[0161] The filtered solution is concentrated under reduced pressure at 45°C until the volume is reduced to 1 / 5 of the original volume; then the extract is freeze-dried to obtain the Gentiana scabra root extract.
[0162] In this embodiment, a mousse-type sunscreen is provided, which is prepared according to the method of Example 1, and the order of adding the replaced components is unchanged.
[0163] Performance test
[0164] Test 1: The sunscreens prepared in Examples 1-7 are tested for their properties, and whether they are in the form of mousse is observed. Then, the sunscreens prepared in Examples 1-7 are respectively placed at 5°C and 45°C for 180 days, and the properties and whether they can stably maintain the mousse form are observed. The sunscreens prepared in Examples 1-7 are placed at 40°C for 12 h and at room temperature for 12 h, and the cycle is repeated for 10 times, and the properties are observed. The results are shown in Table 1. (During the test, transparent bottles are used for storage)
[0165] Table 1: Test results of Test 1
[0166]
[0167] "-" means that the relevant experiment was not performed
[0168] Test 2: Human skin patch test
[0169] Materials and methods
[0170] 1. Test substance: Examples 1-7.
[0171] 2. Negative control: blank control.
[0172] 3. Subjects: A total of 56 people, 23 men and 33 women, aged 20-50 years, with an average age of 31.1±3.2 years, who met the voluntary selection criteria for subjects.
[0173] 4. Patch test method: qualified patch test equipment was selected, and about 0.020 mL-0.025 mL of the test substance was placed in the patch test device using a closed patch test method. A low-sensitization adhesive tape was applied to the flexor of the forearm of the subject. After 24 hours, the test substance was removed, and skin reactions were observed at 0.5, 24, and 48 hours after removal, respectively. The results were recorded according to the skin reaction grading standard in the "Cosmetic Safety Technical Specification" (2015 edition).
[0174] Table 2 Summary of human skin patch test results
[0175]
[0176]
[0177] Test 3: Determination of SPF value of sunscreen cosmetic
[0178] Materials and methods
[0179] 1. Test substance: Examples 1-6.
[0180] 2. Control: SPF value 20.1±2.4, prepared according to the standard formulation of high SPF standard (P2) in the "Cosmetic Safety Technical Specification" (2015 edition).
[0181] 3. Subjects: A total of 26 people, 1 man and 25 women, aged 25-45 years, with an average age of 32.1±2.6 years, who met the voluntary selection criteria for subjects.
[0182] 4. Light source: Sunlight simulator xenon arc lamp, with performance indicators meeting the requirements of the determination specification.
[0183] 5. Test method: The test was conducted according to the specific requirements of the “Cosmetic Safety Technical Specifications” (2015 edition). The subjects were in a prone position, and their backs were irradiated. The minimum erythema dose (MED value) of the subjects' skin to ultraviolet irradiation was predicted 24 hours before the test, and the ultraviolet irradiation dose was adjusted according to the prediction results for the test of the measured object. On the test day, a normal skin area of not less than 30 cm 2 was first selected on the back of the subject, and the measured object or the control was uniformly applied to the above-mentioned area at a dosage of (2.00 ± 0.05) mg / cm 2 , and then the irradiation dose was selected according to the requirements of the specifications, and irradiation was performed in three cases: ① the skin of the subject was not coated with the measured object; ② the control was coated; and ③ the measured object was coated. The experimental results were observed after 24 hours, and the MED values in the three cases were recorded, respectively.
[0184] 6. SPF value calculation method: The SPF value of the measured object or the control for protecting a single subject was represented by the following formula:
[0185] SPFi = MED value of protected skin / MED value of unprotected skin * 100%
[0186] The individual SPF value was required to be accurate to one decimal place, and the arithmetic mean of the SPF value of the measured object for protecting all subjects was taken as the integer part, which was the SPF value of the measured sample. The sampling error of the estimated mean could be calculated as the standard deviation and the standard error. The 95% confidence interval (95% CI) of the mean was required to be not more than 17% of the mean, otherwise the number of subjects should be increased (not more than 25) until the above requirements were met.
[0187] Table 3 SPF determination results
[0188] Example Control SPF value Test SPF value Example 1 20.1 47.26 Example 2 19.9 43.14 Example 3 20.2 44.32 Example 4 20.0 39.43 Example 5 20.1 45.01 Example 6 19.8 45.35
[0189] Test 4: Long-wave ultraviolet protection factor (PFA value) determination of sunscreen cosmetics
[0190] 1. Measured object: Examples 1-6.
[0191] 2.2. Control: PFA value 4.4 ± 0.6, prepared according to the standard formula of the PFA standard of the “Cosmetic Safety Technical Specifications” (2015 edition).
[0192] 3. Subjects: A total of 26 people, 1 male and 25 females, aged 25-45 years, with an average age of 32.1 ± 2.6 years, meeting the subject's voluntary selection criteria.
[0193] 4. Light source: Sunlight simulator xenon arc lamp, with performance indicators meeting the requirements of the determination specifications
[0194] 5. Test method: The test was performed according to the requirements of the "Cosmetic Safety Technical Specifications" (2015 edition). The subjects were in a prone position, and their backs were irradiated. The minimum pigmentation dose (MPPD value) of the subjects' skin to ultraviolet irradiation was predicted 24 hours before the test, and the amount of ultraviolet irradiation was adjusted according to the prediction results for the test of the measured object. The test first selected a normal skin area of not less than 30 cm 2 on the back of the subject, and then uniformly applied the measured object or the control product in an amount of (2.00 ± 0.05) mg / cm 2 on the above area; then selected the UVA irradiation amount according to the requirements of the specification, and irradiated in three cases: ① the subject's skin without the measured object; ② with the control product; and ③ with the measured object. The experimental results were observed after 2-4 hours, and the MPPD values under the three conditions were recorded.
[0195] 6. Calculation method of PFA value: The PFA value of the measured object or the control product to protect a single subject was represented by the following formula:
[0196] PFAi = MPPD value of protected skin / MPPD value of unprotected skin * 100%
[0197] The individual PFA value was required to be accurate to one decimal place, the arithmetic mean of the PFA values of the measured object to protect all subjects was calculated, and the integer part was the PFA value of the measured sample. The sampling error of the estimated mean could be calculated by the standard deviation and the standard error, and the 95% confidence interval (95% CI) of the mean was required to be not more than 17% of the mean, and the number of subjects was increased until the above requirements were met, but the maximum number of subjects was 25.
[0198] Table 4 PFA test results
[0199] Example Control PFA value Test PFA value Example 1 4.5 18.58 Example 2 4.6 16.19 Example 3 4.4 16.32 Example 4 4.5 14.15 Example 5 4.7 17.12 Example 6 4.6 17.43
[0200] Test 5: The products prepared in Examples 1-6 were subjected to sunscreen questionnaire testing, and 40 subjects were selected, aged 20-45 years old, 10 males and 30 females. Among them, 28 subjects with oily or mixed skin and 12 subjects with dry skin were confirmed.
[0201] The questionnaire content is shown in Table 5.
[0202] Table 5 Sunscreen subject questionnaire content
[0203]
[0204]
[0205] 5 means complete agreement, 4 means more agreement, 3 means both agreement and disagreement (i.e. neutral), 2 means more disagreement, and 1 means complete disagreement. The results were numerically integrated for 40 subjects.
[0206] Table 6 Sunscreen Subject Questionnaire Results
[0207] Example Question 1 Question 2 Question 3 Question 4 Question 5 Question 6 Question 7 Question 8 1 199 199 200 198 197 191 199 198 2 190 185 186 183 190 187 181 176 3 193 187 182 182 189 185 180 175 4 191 187 179 180 178 174 179 170 5 196 191 191 188 192 190 186 181 6 185 172 170 164 182 180 171 161
[0208] Finally, it should be noted that the above embodiments are merely used to illustrate the technical solutions of the present application, rather than limiting them. Although the present application has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that they can still modify the technical solutions recorded in the foregoing embodiments, or make equivalent replacements for some or all of the technical features. Such modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present application.
Claims
1. A mousse-type sunscreen cosmetic composition, characterized in that, Comprising by weight: Ethylhexyl methoxycinnamate 1.3%, Butylhydroxytoluene 5.1%, Butylene glycol 3.25%, Methyl methacrylate crosspolymer 1.54%, Glyceryl polyether-26 3.14%, Diethylamino hydroxybenzoyl hexyl benzoate 3.4%, Cetyl alcohol 0.35%, Glyceryl stearate 0.25%, PEG-75 stearate 0.2, Cetyl alcohol polyether-200.25, Stearyl alcohol polyether-200.25, Ethylhexyl palmitate 3.5, Ethylhexyl triazine 2.1, Isononyl isononanoate 3.2, Polydimethylsiloxane 3.2, 1,2-Hexanediol 0.85, Sorbitan oleate 0.32, p-Hydroxyacetophenone 0.4, Silica 1.3, Butylene glycol 0.75, Gentiana scabra root extract 0.7, Sodium polyacrylate 0.3, Potassium cetyl phosphate 0.5, Tocopheryl acetate 0.18, Acrylates / C10-30 Alkyl acrylate crosspolymer 0.3, Sodium hydroxide 1.7, Bis-ethylhexyloxyphenol methoxyphenyl triazine 0.18, Butylene glycol 0.03, Medicinal Fomembrane (FOMES) OFFICINALIS extract 4.0, phenoxyethanol 0.01, PEG-40 hydrogenated castor oil 0.05, butylene glycol 0.03, oat (AVENA SATIVA) kernel extract 3.5, 1,2-pentanediol 0.02, tocopherol 0.1, tetrahydromethylpyrimidine carboxylic acid 0.05, octyldodecylphenyltriazole 0.05 parts, water to make up to 100 parts; The preparation method of the medicinal FOMES OFFICINALIS extract is as follows: (1) The medicinal strain of *Polyporus flocculationii* was cultured on 7% MS agar medium for 5-7 days to obtain the activated strain; (2) Inoculate the activated strain into 50 mL of liquid culture medium and culture it in a shaker at 25℃ and 150 rpm for 2-3 days to prepare the inoculum; liquid culture medium: glucose 20 g / L, yeast extract 5 g / L, malt extract 10 g / L, ginsenoside 1 g / L, water 1 L; (3) Inoculate the pre-cultured bacterial culture into the liquid culture medium in a 1 L fermenter at an inoculation rate of 5-10%. The fermentation process lasts for 7-14 days. Control the fermentation temperature at 25-28℃. Adjust the aeration rate to 1 vvm and set the stirring speed to 150-200 rpm. (4) Separate the extract prepared in step (3) to obtain the supernatant; then add three times the volume of ethanol to the supernatant, separate the precipitate, and take the supernatant to obtain the medicinal FOMES OFFICINALIS extract. The preparation method of the gentian (Gentiana scabra) root extract is as follows: Mix gentian root powder with 70% ethanol at a mass / volume ratio of 1:
10. The mixture was subjected to ultrasonic extraction in an ultrasonic instrument with an ultrasonic power set to 300W for 30 minutes and the temperature controlled at 60℃. After extraction, the extract was cooled to room temperature. The extracted solution was filtered to remove residues and concentrated under reduced pressure at 45°C until the volume was reduced to 1 / 5 of the original volume. The extract was then freeze-dried to obtain Gentiana scabra root extract.
2. A mousse-type sunscreen agent, prepared from the composition of claim 1.
3. The sunscreen agent according to claim 2, wherein the preparation method comprises the following steps: (1) Soak and disperse phase A raw material until it is uniform beforehand, and set aside; (2) Add phase B raw material to the vacuum emulsification pot, turn on the stirring, heat to 75-80℃, add phase A, vacuum, homogenize for 5 minutes, check that the material is completely mixed, and keep warm for 5-10 minutes. (3) Add the C phase raw material to the oil pot, stir and heat to 80-85℃, keep warm for 3-5 minutes and then transfer it to the emulsification pot, homogenize for 5-7 minutes, and start cooling after the material is uniform and free of particles. (4) When the temperature drops to 45℃, add the D phase raw material, homogenize and stir for 3 minutes, vacuum defoam, and cool down. (5) Cool down to 35-38℃, send for testing, and after passing the test, filter the material through a 200-mesh filter; take samples for testing and transfer the material. (6) After passing inspection, the product is filled and packaged; after passing inspection, the finished product is put into storage. in, The following is stated: Phase A raw materials: 1 / 3 part water, sodium polyacrylate, potassium cetyl phosphate, acrylate (ester) crosslinker / C10-30 alkanol acrylate; Phase B raw materials: residual water, butanediol, glycerol polyether-26, p-hydroxyacetophenone; C-phase raw materials: Ethylhexyl methoxycinnamate, Butylated hydroxytoluene, Diethylamino hydroxybenzoyl hexyl benzoate, Cetyl alcohol, Glyceryl stearate, PEG-75 stearate, Cetyl alcohol polyether-20, Stearyl alcohol polyether-20, Ethylhexyl palmitate, Ethylhexyl triazine, Isononyl isononanoate, Polydimethylsiloxane, Sorbitan oleate, Silica, Tocopheryl acetate, Bis-ethylhexyloxyphenol methoxyphenyl triazine, Octyldodecylphenyltriazole; D-phase raw materials: Remaining raw materials.
Citation Information
Patent Citations
Sunscreen lotion and preparation method thereof
CN112516022A
Sunscreen composition with foaming function as well as preparation method and application thereof
CN117243858A